antibiotics

AstraZeneca to carve out antibiotic R&D into separate firm
Yahoo/Reuters
Fri, 02/27/15 - 11:20 am
AstraZeneca
antibiotics
R&D
spinoffs
Actavis wins FDA approval for a new 'superbug' antibiotic
Fierce Biotech
Thu, 02/26/15 - 09:29 am
Actavis
FDA
superbugs
antibiotics
Avycaz
The Need For New Antibiotics, $2 Billion Prizes, And Drug Pricing
Forbes
Tue, 02/24/15 - 04:57 pm
antibiotics
drug pricing
Superbug Spread Reveals Thin Pipeline of Newest Antibiotics
Bloomberg
Fri, 02/20/15 - 11:21 am
superbugs
antibiotics
antibiotic resistance
Antibiotics firm Motif Bio to tap UK market for cash
Yahoo/Reuters
Sun, 02/1/15 - 10:24 am
Motif Biosciences
antibiotics
Obama wants to pour $1.2B into antibiotic R&D
Fierce Biotech
Tue, 01/27/15 - 10:53 am
R&D
antibiotics
Obama
U.S. Senators Re-Introduce a Bill to Speed Approval of Antibiotics
WSJ Pharmalot
Mon, 01/19/15 - 04:03 pm
Senate
drug approvals
antibiotics
Drug companies to blame for antibiotic resistance, says pharmaceutical boss
The Telegraph, UK
Sun, 01/18/15 - 10:57 am
antibiotic resistance
antibiotics
Teixobactin and iChip Promise Hope Against Antibiotic Resistance
Forbes
Thu, 01/8/15 - 08:03 am
Teixobactin
iChip
antibiotic resistance
antibiotics
Cubist: Zerbaxa Upholds The Potential To Replace Cubicin
Seeking Alpha
Mon, 01/5/15 - 04:06 pm
Cubist Pharma
antibiotics
Zerbaxa
Cubicin
Merck
Cempra Oral Antibiotic Effective Against Hard-to-Treat Pneumonia
TheStreet.com
Mon, 01/5/15 - 09:10 am
Cempra
antibiotics
Solithromycin
community acquired bacterial pneumonia
FDA approves Cubists' drug for antibiotic-resistant bacteria
Yahoo/Reuters
Sat, 12/20/14 - 10:12 am
Cubist Pharmaceuticals
Zerbaxa
antibiotics
Tetraphase spikes on a Phase III success for lead antibiotic
Fierce Biotech
Wed, 12/17/14 - 09:41 pm
antibiotics
Tetraphase Pharmaceuticals
Eravacycline
Achaogen Is Well-Positioned To Ride The New Tide Of Interest In Antibiotics
Seeking Alpha
Wed, 12/10/14 - 09:53 am
Achaogen
antibiotics
plazomicin
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
WSJ Online
Wed, 12/10/14 - 08:13 am
Merck
Cubist Pharma
M&A
Cubicin
antibiotics
Cubist Barred From Blocking Generic Cubicin Beyond 2016
Bloomberg
Tue, 12/9/14 - 08:06 am
Cubist Pharma
Merck
Cubicin
antibiotics
Merck Triggers The Race to Replace Cubist
Forbes
Mon, 12/8/14 - 03:49 pm
Merck
Cubist Pharma
M&A
antibiotics
antibiotic resistance
Did Novartis Make a Ham-Handed Move to Promote an Antibiotic for Pigs?
WSJ Pharmalot
Thu, 10/30/14 - 12:18 pm
Novartis
animal health
antibiotics
antibiotic resistance
Is AstraZeneca Getting Ready to Exit Antibiotics Research?
WSJ Pharmalot
Fri, 10/24/14 - 10:08 am
AstraZeneca
antibiotics
R&D
Could Pay-For-Performance Lead To Overuse Of Antibiotics?
Forbes
Tue, 09/30/14 - 12:40 pm
antibiotics

Pages